Prevention of allopurinol-associated adverse cutaneous drug reactions in high-risk patient groups in Canada.
作者信息
Ponzo Marisa, Dutz Jan
机构信息
Clinical instructor, Department of Dermatology and Skin Sciences, University of British Columbia, Vancouver, BC.
Department head, Department of Dermatology and Skin Sciences, University of British Columbia, Vancouver, BC.
出版信息
CMAJ. 2020 Feb 18;192(7):E168. doi: 10.1503/cmaj.74133.
Abstract
摘要
相似文献
1
Prevention of allopurinol-associated adverse cutaneous drug reactions in high-risk patient groups in Canada.
CMAJ. 2020 Feb 18;192(7):E168. doi: 10.1503/cmaj.74133.
2
Genotyping HLA-B*5801 for Allopurinol-Induced Severe Cutaneous Adverse Reactions: An Accurate and Prompt Method.
Clin Transl Sci. 2015 Dec;8(6):834-6. doi: 10.1111/cts.12365. Epub 2015 Dec 14.
3
Impact of the HLA-B(*)58:01 Allele and Renal Impairment on Allopurinol-Induced Cutaneous Adverse Reactions.
J Invest Dermatol. 2016 Jul;136(7):1373-1381. doi: 10.1016/j.jid.2016.02.808. Epub 2016 Mar 18.
4
Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population-based cohort study.
CMAJ. 2019 Sep 30;191(39):E1070-E1077. doi: 10.1503/cmaj.190339.
5
Genetic markers associated with cutaneous adverse drug reactions to allopurinol: a systematic review.
Pharmacogenomics. 2015;16(7):755-67. doi: 10.2217/pgs.15.21. Epub 2015 May 12.
6
Pharmacogenetics of allopurinol--making an old drug safer.
J Clin Pharmacol. 2013 Jul;53(7):675-9. doi: 10.1002/jcph.67. Epub 2013 Feb 4.
7
Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.
J Allergy Clin Immunol Pract. 2019 Jan;7(1):219-227.e4. doi: 10.1016/j.jaip.2018.05.004. Epub 2018 May 22.
8
Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach.
Pharmacogenomics. 2017 Jun;18(9):881-890. doi: 10.2217/pgs-2017-0016. Epub 2017 Jun 8.
9
Initiation Dose of Allopurinol and the Risk of Severe Cutaneous Reactions in Older Adults With CKD: A Population-Based Cohort Study.
Am J Kidney Dis. 2022 Dec;80(6):730-739. doi: 10.1053/j.ajkd.2022.04.006. Epub 2022 May 27.
10
Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction.
J Allergy Clin Immunol. 2015 Apr;135(4):1063-1065.e5. doi: 10.1016/j.jaci.2014.09.041. Epub 2014 Nov 11.
本文引用的文献
1
Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population-based cohort study.
CMAJ. 2019 Sep 30;191(39):E1070-E1077. doi: 10.1503/cmaj.190339.
2
Genotyping to Prevent Cases of DRESS and SJS/TEN in East Asians Treated with Allopurinol-A Canadian Missed Opportunity.
J Cutan Med Surg. 2019 Nov/Dec;23(6):595-601. doi: 10.1177/1203475419867599. Epub 2019 Aug 5.
Zotero 插件